Table 8 The BW and BMI change in responder group and none-responder groups when subdivided according to different AAPs ()
Two groups a | AAP b | N | BW change (kg) | P-value | BMI change | P-value |
|---|---|---|---|---|---|---|
responder group | clozapine | 63 | 0.60 ± 3.94 | 0.012 | 0.21 ± 1.41 | 0.009 |
|  | risperidone | 115 | 1.20 ± 3.71 |  | 0.46 ± 1.41 |  |
|  | olanzapine | 25 | 1.94 ± 4.47 |  | 0.76 ± 1.68 |  |
|  | quetiapine | 76 | 1.01 ± 3.41 |  | 0.37 ± 1.26 |  |
|  | ziprasidone | 32 | -1.66 ± 4.78 |  | -0.60 ± 1.74 |  |
|  | aripiprazole | 26 | -0.67 ± 4.42 |  | -0.19 ± 1.49 |  |
none-responder group | clozapine | 7 | -1.57 ± 2.30 | 0.917 | -0.55 ± 0.80 | 0.834 |
|  | risperidone | 11 | -1.18 ± 1.99 |  | -0.47 ± 0.79 |  |
|  | olanzapine | 5 | -0.60 ± 1.82 |  | -0.18 ± 0.62 |  |
|  | quetiapine | 8 | -0.44 ± 2.87 |  | -0.16 ± 1.07 |  |
|  | ziprasidone | 6 | -1.5 ± 2.74 |  | -0.56 ± 0.95 |  |
|  | aripiprazole | 3 | -1.8 ± 3.69 |  | -0.73 ± 1.42 |  |